New PATH Study Data Files From Wave 8 Now Available

New Wave 8 Public-Use Files from the Population Assessment of Tobacco and Health (PATH) Study are now available from FDA’s Center for Tobacco Products and the National Institutes of Health’s National Institute on Drug Abuse. These Wave 8 files contain questionnaire data collected between January 2024 and December 2024.

In addition, the updated PATH Study Wave 7 Biomarker Restricted-Use File now includes new tobacco-specific nitrosamine and F2-isoprostane data from the Wave 7 Biomarker Core.

Researchers may submit a request to obtain access to all currently available Biomarker Restricted-Use Files and Restricted-Use Files. Data and documentation from the Public-Use Files are available for download along with updated Master Linkage Files.

The PATH Study is a household-based, nationally representative, longitudinal study of adults and youth (12-17 years old) in the United States studying tobacco use patterns and how tobacco products affect health. The study launched in 2011 to inform FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act.

Submit questions about the collection, content, weighting, documentation, or structure of PATH Study data to PATHDataUserQuestions@Westat.com.